Squarepoint
ZYME icon

Squarepoint’s Zymeworks ZYME Stock Holding History

Squarepoint’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Sell
16,200
-66,946
-81% -$1.7M ﹤0.01% 3552
2026
Q1 		$2.08M Buy
+83,146
New +$1.97M ﹤0.01% 2149
2025
Q4 		– Sell
-219,948
Closed -$3.76M – 5010
2025
Q3 		$3.76M Buy
219,948
+64,349
+41% +$921K ﹤0.01% 1635
2025
Q2 		$1.95M Buy
155,599
+91,997
+145% +$1.1M ﹤0.01% 2122
2025
Q1 		$758K Buy
+63,602
New +$867K ﹤0.01% 2901
2024
Q4 		– Sell
-33,438
Closed -$420K – 5574
2024
Q3 		$420K Sell
33,438
-39,886
-54% -$434K ﹤0.01% 3227
2024
Q2 		$624K Buy
73,324
+58,716
+402% +$523K ﹤0.01% 2910
2024
Q1 		$154K Buy
+14,608
New +$162K ﹤0.01% 3699
2023
Q2 		– Sell
-78,504
Closed -$710K – 4096
2023
Q1 		$710K Buy
+78,504
New +$685K ﹤0.01% 2102
2022
Q3 		– Sell
-235,285
Closed -$1.25M – 3524
2022
Q2 		$1.25M Buy
+235,285
New +$1.42M 0.01% 1469
2021
Q3 		– Sell
-28,975
Closed -$1M – 3511
2021
Q2 		$1M Buy
28,975
+18,984
+190% +$602K ﹤0.01% 1626
2021
Q1 		$316K Buy
+9,991
New +$406K ﹤0.01% 2358
2020
Q4 		– Sell
-8,806
Closed -$410K – 3315
2020
Q3 		$410K Sell
8,806
-8,456
-49% -$290K 0.01% 1582
2020
Q2 		$623K Buy
17,262
+3,746
+28% +$138K 0.01% 1184
2020
Q1 		$479K Buy
13,516
+1,916
+17% +$78.4K 0.01% 1069
2019
Q4 		$527K Buy
+11,600
New +$422K ﹤0.01% 1750
2018
Q4 		– Sell
-30,097
Closed -$473K – 2280
2018
Q3 		$473K Sell
30,097
-8,534
-22% -$122K 0.01% 1324
2018
Q2 		$571K Buy
+38,631
New +$598K 0.01% 1128

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Squarepoint's ZYME Position: Q2 2026 in Review

Squarepoint reduced its Zymeworks (ZYME) stake by 81% in Q2 2026, selling an estimated $1.7M and leaving 16,200 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #3552.

Squarepoint first reported a position in ZYME in Q2 2018 and has held it in 18 quarters since. The position peaked at $3.76M in Q3 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Squarepoint held 16,200 shares of Zymeworks worth $423K as of Q2 2026.
  • Squarepoint sold 66,946 Zymeworks shares in Q2 2026, an estimated $1.7M.
  • Zymeworks made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3552 holding.
  • Squarepoint first reported a position in Zymeworks in Q2 2018 and has held it in 18 quarters since.
  • Squarepoint's Zymeworks position peaked at $3.76M in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.